<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The choice of antiarrhythmic therapy for <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> is directly dependent on the clinical presentation </plain></SENT>
<SENT sid="1" pm="."><plain>This article describes the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> attacks associated with paroxysmal forms, and also of more persistent forms </plain></SENT>
<SENT sid="2" pm="."><plain>First-line relapse prevention is based on antiarrhythmic drugs, but other options such as atrial catheter ablation have recently been developed </plain></SENT>
<SENT sid="3" pm="."><plain>Ablation of the <z:mpath ids='MPATH_458'>normal</z:mpath> conducting atrioventricular pathway and direct atrial surgery are also discussed </plain></SENT>
</text></document>